AC Immune
ACIU
ACIU
36 hedge funds and large institutions have $57.2M invested in AC Immune in 2022 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 10 increasing their positions, 13 reducing their positions, and 10 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
23% less capital invested
Capital invested by funds: $74.5M → $57.2M (-$17.3M)
70% less first-time investments, than exits
New positions opened: 3 | Existing positions closed: 10
Holders
36
Holding in Top 10
–
Calls
$942K
Puts
$439K
Top Buyers
| 1 | +$1.46M | |
| 2 | +$404K | |
| 3 | +$309K | |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$98.3K |
| 5 |
HF
HRT Financial
New York
|
+$42K |
Top Sellers
| 1 | -$1.72M | |
| 2 | -$1.06M | |
| 3 | -$956K | |
| 4 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$362K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$294K |